Galactose-3-O-Sulfotransferase 1-4 (GAL3ST1-4)
Reference51 articles.
1. Balbaa M, Honke K, Makita A (1996) Regulation of glycolipid sulfotransferase by tyrosine kinases in human renal cancer cells. Biochim Biophys Acta 1299:141–145
2. Capon C, Wieruszeski JM, Lemoine J, Byrd JC, Leffler H, Kim YS (1997) Sulfated Lewis x determinants as a major structural motif in glycans from LS174T-HM7 human colon carcinoma mucin. J Biol Chem 272:31957–31968
3. Cheng X, Zhang Y, Kotani N, Watanabe T, Lee S, Wang X, Kawashima I, Tai T, Taniguchi N, Honke K (2005) Production of a recombinant single-chain variable-fragment (scFv) antibody against sulfoglycolipid. J Biochem 137:415–421
4. Eckhardt M, Fewou SN, Ackermann I, Gieselmann V (2002) N-glycosylation is required for full enzymic activity of the murine galactosylceramide sulphotransferase. Biochem J 368:317–324
5. El-Fasakhany FM, Uchimura K, Kannagi R, Muramatsu T (2001) A novel human Gal-3-O-sulfotransferase: molecular cloning, characterization and its implications in biosynthesis of 3′-sulfo Lewisx. J Biol Chem 276:26988–26994